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Abstract
Objective:  To  assess  the  relationship  between  mouth  breathing  and  growth  disorders  among
children and  teenagers.
Data  source:  Search  on  MEDLINE  database,  over  the  last  10  years,  by  using  the  following  terms:
‘‘mouth  breathing’’,  ‘‘adenotonsilar  hypertrophy’’,  ‘‘allergic  rhinitis’’,  ‘‘sleep  disturbance’’
AND ‘‘growth  impairment’’,  ‘‘growth  hormone’’,  ‘‘failure  to  thrive’’,  ‘‘short  stature’’,  or
‘‘failure to  thrive’’.
Data  summary:  A  total  of  247  articles  were  identified  and,  after  reading  the  headings,  this
number was  reduced  to  45  articles,  whose  abstracts  were  read  and,  of  these,  20  were  deemed
important  and  were  included  in  the  review.  In  addition  of  these  articles,  references  mentioned
in them  and  specific  books  on  mouth  breathing  deemed  important  were  included.  Hypertrophy  of
palatine and/or  pharyngeal  tonsils,  whether  associated  with  allergic  rhinitis,  as  well  as  poorly
controlled  allergic  rhinitis,  are  the  main  causes  of  mouth  breathing  in  children.  Respiratory
sleep disorders  are  frequent  among  these  patients.  Several  studies  associate  mouth  breathing
with reduced  growth,  as  well  as  with  reduced  growth  hormone  release,  which  are  reestablished
after effective  treatment  of  mouth  breathing  (clinical  and/or  surgical).
Conclusions:  Mouth  breathing  should  be  considered  as  a  potential  cause  of  growth  retardation
in children;  pediatricians  should  assess  these  patients  in  a  broad  manner.JPED 761 1--6
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PALAVRAS-CHAVE
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Hipertrofia  de
amígdala;
Respirador  oral;
Crescimento
Crescimento  e  respiradores  orais
Resumo
Objetivo:  Foi  objetivo  deste  artigo  avaliar  a  relac¸ão  entre  respirac¸ão  oral  e  distúrbios  do
crescimento  entre  crianc¸as  e  adolescentes.
Fonte  de  dados:  Busca  na  base  de  dados  do  MEDLINE,  nos  últimos  10  anos,  empregando  os
seguintes  termos:  ‘‘mouth  breathing’’  ou  ‘‘adenotonsilar  hypertrophy’’,  ou  ‘‘allergic  rhinitis’’
ou sleep  disturbance’’  AND  ‘‘growth  impairment’’  ou  ‘‘growth  hormone’’  ou  ‘‘failure  to  thrive’’
ou ‘‘short  stature’’  ou  ‘failure  to  thrive’’.
Síntese  dos  dados:  Foram  identificados  247  artigos  que  após  a  leitura  dos  títulos  foram  reduzi-
dos a  45  cujos  resumos  foram  lidos  e  destes  20  foram  considerados  de  importância  e  integraram  a
revisão. Além  desses,  referências  por  eles  citadas  e  livros  texto  específicos  sobre  respirac¸ão  oral
considerados  importantes  foram  incluídos.  A  hipertrofia  de  tonsilas  palatinas  e/ou  faríngeas,
associadas  ou  não  à  rinite  alérgica,  assim  como  a  rinite  alérgica  mal  controlada  são  as  principais
causas de  respirac¸ão  oral  na  crianc¸a.  Distúrbios  respiratórios  do  sono  são  frequentes  entre  esses
pacientes.  Vários  estudos  associam  a  respirac¸ão  oral  à  reduc¸ão  do  crescimento,  bem  como  à
reduc¸ão de  liberac¸ão  de  hormônio  do  crescimento,  que  são  restabelecidos  após  o  tratamento
efetivo da  respirac¸ão  oral  (clínico  e/ou  cirúrgico).
Conclusões:  A  respirac¸ão  oral  deve  ser  cogitada  como  possível  causa  de  retardo  de  crescimento
em crianc¸as  e  cabe  ao  pediatra  a  tarefa  de  investigar  esses  pacientes  de  forma  mais  abrangente.
© 2018  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´ um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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Sleep disturbance
Allergic rhinitis
Mouth breathing
Growth hormone
Failure to thrive
Short stature
Growth impairment
AND
20 Articles included in the review
45 Relevant for the review
247 Articles (last 10 years)
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 mouth  breather  is  every  individual  who  breaths  through
he  mouth  as  a  result  of  a  pathological  adaptation,  whether
n  the  presence  of  nasal  and/or  pharyngeal  obstruction.1
he  primary  function  of  the  nose  is  to  bring  the  inhaled
ir  to  the  lungs  under  ideal  conditions  for  hematosis,  i.e.,
eated,  humidified,  and  free  of  microorganisms  and  pollu-
ants  present  in  room  air.2
In  children,  nasal  breathing  is  more  important  than  in
dults.  At  birth,  nasal  breathing  is  a  mandatory  condition
ue  to  the  high  position  of  the  larynx  in  comparison  with
he  oral  cavity,  which  allows  the  newborn  to  be  breastfed
nd  breathe.  The  high  location  of  the  epiglottis,  in  this  case,
akes  it  difficult  for  air  to  enter  the  lower  airways  when  the
ow  comes  from  the  mouth,  causing  an  intense  respiratory
iscomfort  in  the  presence  of  bilateral  nasal  obstruction.1,2
Additionally,  nasal  breathing  in  children  aids  the  growth
f  central  facial  bones  and  the  functional  arrangement  of
ll  the  muscles  related  to  breathing  and  chewing.1,2 Under
hronic  nasal  obstruction  conditions,  an  underdevelopment
f  the  palatal  processes  of  maxilla  may  be  observed,  leading
o  the  appearance  of  high  arched  hard  palate.  Addition-
lly,  mouth  breathing  requires  several  muscular  and  postural
daptations  to  adjust  to  a  new  form  of  breathing,  chewing,
nd  even  swallowing  food.2
Lowering  of  the  mandible,  hypotonic  lip  musculature,
nd  changes  in  the  phases  of  swallowing  are  common  find-
ngs  in  these  children  and,  if  unidentified  and  treated  early,
an  become  irreversible.  Furthermore,  mouth  breathing
oncomitant  to  nasal  obstruction  may  predispose  to  air-
ay  collapse  and,  consequently,  respiratory  sleep  disorders
RSD).  Fig.  1  presents  the  article  search  method  papers  used
n  this  review.
C
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figure  1  Search  method  in  MEDLINE  database  (last  10  years).
revalence of mouth breathers
he  prevalence  of  chronic  mouth  breathing  in  children  has
een  hardly  studied  and  its  distribution  in  the  different  age
roups  is  unknown.  Values  between  3.4%  and  56.8%  have
een  documented  based  on  the  studied  population  (healthy,
ith  dental,  respiratory  problems,  or  others),  age  group
ssessed,  and  diagnosis  method  used  (questionnaire,  physi-
al  examination).3--5
linical statusJPED 761 1--6
hronic  mouth  breathing  may  determine  skeletal  and
yofunctional  changes  that  hinder  facial  growth.
any  children  with  mouth  breathing  present  elongated
acies,  incomplete  lip  closure,  shortened  upper  lip  with
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190Figure  2  Y-axis  of  facial  growth  (represented  by  the  opening
of the  NS-Gn  angle).
accentuated  concavity,  everted  lower  lip,  and  presence
of  dark  circles,  characterizing  adenoid  facies.6--9 At
cephalometric  evaluation,  an  increased  Y-axis  is  observed
(Fig.  2).
The  presence  of  snoring,  whether  associated  with  apnea
or  respiratory  distress  during  sleep,  is  a  frequent  complaint
among  parents  or  caregivers,  followed  by  restless  sleep,
frequent  night  awakenings,1 bruxism,11 and  sometimes
somnambulism.10--12 Mouth  breathing  is  often  associated
with  other  harmful  oral  habits,  such  as  thumb  sucking,  paci-
fier  sucking,  sucking  and  biting  the  lips,  and  nail  biting,
among  others,  impacting  quality  of  life.13
Chewing,  swallowing,  and  speech  problems  (linguodental
phonemes)  are  also  observed.  Maxillary  arch  atresia  and  the
presence  of  high  arched  palate  are  common  findings  asso-
ciated  with  cross-bite,  which  can  already  be  observed  in
preschool  children.6--10
In  addition,  the  presence  of  RSDs,  such  as  snoring,
increased  airway  resistance,  or  even  apnea,  is  common
among  these  patients;  its  frequency  ranges  from  3.3%  (chil-
dren  at  5--6  years)  to  42%  (mouth  breathers).5 Obstructive
sleep  apnea  syndrome  (OSAS)  is  the  most  severe  form
of  RSD,  and  affected  children  may  have  neurocognitive
impairment  due  to  attention  and  concentration  deficits,
hyperactivity,  morning  tiredness,  decreased  conceptual,
verbal  and  non-verbal  reasoning  skills,  school  disorders,14,15
or  even  delayed  weight  and  height  gain.1,2 Currently,  cor
pulmonale16 and  systematic  arterial  hypertension17 are  very
rare  complications  associated  with  OSAS.
Etiology of mouth breathing in children
Among  the  several  causes  of  mouth  breathing  in  children,
the  most  frequent  are  hypertrophy  of  pharyngeal  (adenoids)
and/or  palatine  tonsils  (amygdala)  and  untreated  (and,
therefore,  uncontrolled)  allergic  rhinitis.  Nonetheless,  other
etiologies  should  also  be  considered:  unilateral  or  bilateral
choanal  atresia,  anatomical  variations  of  the  nasal  conchae,
nasal  foreign  body,  septal  deformities  or  nasal  masses,  and
even  rarer  entities  that  can  cause  nasal  congestion,  such
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s  cystic  fibrosis,  primary  ciliary  dyskinesia,  and  primary
mmunodeficiencies.
Hypertrophy  of  pharyngeal  and/or  palatine  tonsils,  albeit
resent  in  the  early  phase  of  life,  usually  becomes  apparent
round  the  age  of  2  years,  as  it  follows  the  development  of
he  lymphoid  system  and  can  worsen  with  the  advancement
f  age.  Most  of  the  times,  the  diagnosis  is  confirmed  through
 simple  lateral  radiography  of  the  face  and,  in  doubtful
ases,  through  nasofibroscopy.  Hypertrophy  of  the  palatine
onsils  can  be  confirmed  through  a  simple  oroscopy.
Rhinitis  can  be  defined  as  a  symptomatic  inflammation  of
he  nasal  mucous  membrane  and  is  characterized  by  nasal
bstruction,  rhinorrhea  (anterior  and  posterior),  sneezing,
nd  itchy  nose.  It  is  a very  common  problem  since  pre-school
ge  and  can  affect  up  to  40%  of  children.18 Nasal  congestion
s  the  most  frequent  complaint  in  children  with  pre-school
hinitis.19
When  not  properly  controlled,  allergic  rhinitis  can  evolve
o  chronic  nasal  obstruction  and,  consequently,  mouth
reathing.  In  addition  to  the  characteristic  clinical  status,  at
hysical  examination  these  patients  present  ocular  conjunc-
ival  hyperemia,  dark  circles,  transverse  nasal  sulcus,  and
ypertrophied  nasal  conchae,  hindering  the  free  passage  of
ir.  Often,  there  is  an  association  of  allergic  rhinitis  with
haryngeal  tonsil  hypertrophy,20--22 considerably  worsening
he  respiratory  condition.23,24 When  assessed  by  specific
uestionnaires,  children  with  moderate  to  severe  persis-
ent  allergic  rhinitis  present  a higher  frequency  of  sleep
isorders  than  control  children,  especially  in  the  domains
f  nocturnal  respiratory  disorders,  daytime  sleepiness,  and
arasomnias.25,26 Additionally,  there  is  evidence  of  rela-
ionship  between  the  severity  of  allergic  rhinitis  and  the
ntensity  of  sleep  disorders.25,27
Cho  et  al.  confirmed  this  hypothesis  when  studying
he  presence  of  allergic  sensitization  as  a  risk  factor  for
ore  severe  conditions  of  pharyngeal  and/or  palatine  ton-
il  hypertrophy.21 These  authors  measured  allergen-specific
gE  levels  (sIgE)  in  serum  and  tonsillar  tissue  excised  (during
onsil  removal  surgery)  from  102  children  who  were  mouth
reathers  and  had  pharyngeal  tonsil  hypertrophy.  According
o  the  presence  or  absence  of  sIgE,  patients  were  divided
nto  three  groups:  allergic  (serum  and  tissue  sIgE,  n  = 55),
ith  local  allergy  (sIgE  only  at  tissue-level,  n  =  17),  and  with-
ut  allergy  (absent  in  serum  and  tissue,  n  =  32).  In  total
opulation,  70.6  of  the  patients  were  sensible  to  at  least
ne  allergen  (serum  and/or  tissue).  sIgE  tissue  levels  were
ignificantly  higher  than  the  serum  levels,  with  a  predom-
nance  of  sIgE  to  inhalants  in  the  pharyngeal  tonsil  tissue
nd  sIgE  to  food  in  palatine  tonsil.  A  significantly  higher
revalence  of  asthma,  allergic  rhinitis,  more  severe  symp-
oms,  and  greater  consumption  of  relief  medications  were
bserved  among  allergic  patients  when  compared  with  non-
llergic  patients.  These  data  are  unequivocal  evidence  that
he  association  of  allergy  aggravates  the  allergic  conditions
n  these  patients.21 However,  this  fact  was  not  confirmed  in
atients  with  atopic  dermatitis.23JPED 761 1--6
leep and growth
espiratory  sleep  disorders  (RSD,  snoring,  mouth  breathing,
nd  sleep  obstructive  apnea)  were  identified  as  risk  factors
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or  growth  retardation  associated  with  chronic  obstruction
f  the  upper  airways,  whether  due  to  hypertrophy  of  the
haryngeal  and/or  palatine  tonsils  or  allergic  rhinitis.28--35
Sleep  is  defined  as  a  reversible  state  of  perceptual  dis-
ngagement  and  lack  of  response  to  the  environment.36 Two
asic  stages  of  sleep  documented  by  signs  of  cortical  activ-
ty  (electroencephalogram,  EEG),  rapid  eye  movements,  and
uscle  tone  are  identified  in  mammals:  rapid-eye  move-
ent  (REM)  sleep,  and  the  synchronized  or  non-REM  sleep
NREM).36
Simply  put,  sleep  begins  at  the  NREM  stage,  which
s  characterized  by  slow  rotational  ocular  movements,
educed  muscle  tone,  and  fragmented,  low-amplitude  brain
ctivity.37 This  stage  is  composed  of  three  phases:  the  first  is
hort  and  transient,  followed  by  a  second  phase,  in  which  the
rain  activity  has  a  larger  amplitude;  the  third  phase  (deep
leep)  is  characterized  by  slow  waves  of  great  amplitude,
ith  delta  waves  and  release  of  growth  hormone  (GH).
The  second  stage,  called  REM  sleep,  is  not  divided  into
tages;  it  is  characterized  by  rapid  eye  movements,  heart
nd  respiratory  rate  variations,  decreased  blood  pressure
nd  cerebral  blood  flow.  The  mental  activity  during  REM
leep  is  associated  with  dreams,  based  on  the  dream  mem-
ry  reported  after  about  80%  of  the  awakenings  in  this  state
f  sleep.38,39 Sleep  stages  occur  cyclically  at  night  with  the
uccession  of  stages  one  to  three  of  NREM  sleep  and  REM
leep  in  cycles  of  70--110  min,  with  increased  duration  of
EM  sleep  periods  and  reduction  of  slow-wave  sleep.
As  previously  mentioned,  during  the  deep  sleep  or
low-wave  (delta)  sleep  there  is  a  greater  release  of  GH-
eleasing  hormone  (GHRH)  through  the  hypothalamus.40--42
xperimental  studies  in  animals  have  documented  that  the
dministration  of  GHRH  increases  NREM  sleep,  and  the  inhi-
ition  of  its  secretion  suppresses  the  duration  and  depth
f  sleep.43--46 Once  released,  GH  would  act  in  specific  loca-
ions  (through  the  GH-IGF  axis),  performing  its  different
unctions,  among  which  growth.  Changes  in  the  homeosta-
is  of  the  sleep  process  may  interfere  with  the  physiological
elease  of  this  hormonal  network.
outh breathing and growth retardation
vidence  indicates  reduced  pituitary  GH  release  in  individu-
ls  with  airway  obstruction.46 Although  the  cause  of  growth
etardation  is  not  fully  understood,  some  of  the  possible
xplanations  include  low  nocturnal  levels  of  GH,  lack  of
ppetite  and  dysphagia  that  result  in  low  caloric  intake,  noc-
urnal  hypoxemia,  nocturnal  acidosis,  and  increased  energy
onsumption  after  an  increase  in  breathing  work.  Surgical
emoval  of  the  pharyngeal  and  palatine  tonsils  has  been
hown  to  lead  to  resumption  of  normal  growth  for  age  in
hese  children,28--31,47 as  well  as  control  of  allergic  rhinitis.34
An  experimental  study  with  rats  demonstrated  that  upper
irway  obstruction  reduced  the  hypothalamic  and  serum  lev-
ls  of  GHRH,  as  well  as  the  levels  of  GHRH  receptors.43
n  these  animals,  the  waking  time  was  increased  and
low-wave  sleep,  paradoxical  sleep,  and  low-activity  waves
ere  reduced.  The  administration  of  ritanserin  (a  selective
erotonin  receptor  antagonist)  relived  these  effects,  i.e.,
ormalized  the  hypothalamic  content  of  GHRH,  decreased
avelength,  increased  duration  and  depth  of  slow-wave
s
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leep,  and  reduced  growth  retardation  observed  in  these
nimals.  Thus,  the  authors  suggest  that  the  growth  retarda-
ion  observed  in  these  animals  with  upper  airway  obstruction
s  associated  with  hypothalamic  GHRH.43 The  abnormalities
n  the  GHRH/GH  axis  underlie  both,  and  growth  retarda-
ion  and  slow-wave  sleep  associated  with  upper  airway
bstruction.43
In  humans,  the  evaluation  of  patients  with  pharyngeal
nd/or  palatine  tonsil  hypertrophy  has  provided  impor-
ant  insights  for  a  better  understanding  of  the  relationship
etween  airway  obstruction  and  growth  deficit.  A  sys-
ematic  review,  followed  by  meta-analysis,  identified  20
tudies  among  211  citations  evaluating  the  relationship
etween  the  presence  of  hypertrophied  pharyngeal  tonsils,
rowth,  growth  markers,  and  sleep-disordered  breath-
ng  in  children.35 The  joint  review  of  data  of  more
han  300  patients  allowed  to  the  authors  to  effectively
onfirm  the  results  previously  obtained.  When  com-
ared  with  the  pre-operative  period,  significant  increases
ere  observed  in  weight  (minimum  significant  difference
MSD]  =  0.57;  95%  95%  CI  =  0.44--0.70),  height  (MSD  =  0.34;
5%  CI  = 0.20--0.47;  assessed  by  Z-score),  and  serum  lev-
ls  of  IGF-1  (MSD  =  0.53;  95%  CI  =  0.33--0.73)  and  IGFBP-3
MSD  =  0.59;  95%  CI  =  0.34--0.83).  The  authors  concluded  that
rimary  care  physicians  and  specialists  must  consider  RSDs
hen  caring  for  children  with  growth  deficit.35
However,  the  lack  of  homogeneity  in  the  assessed  pop-
lations  was  a limiting  factor  for  the  observed  conclusions,
hich  lead  to  the  development  of  new  studies.  Tatlıpınar
t  al.  assessed  IGF-1  and  IGFBP-3  serum  levels,  as  well  as
he  relationship  between  the  volume  of  pharyngeal  tonsil
nd  nasopharynx  (PT/N)  of  patients  (aged  3--10  years)  with
leep  apnea  secondary  to  pharyngeal  tonsil  hypertrophy.48
he  surgical  removal  lead  to  an  increase  in  weight,  height,
nd  serum  levels  of  IGF-I  and  IGF-BP3.  Nonetheless,  no  sig-
ificant  correlation  was  observed  between  the  increased
iomarkers  and  the  PT/N  index.48
In  more  recent  study  in  pre-pubertal  children  aged  over  5
ears  with  a  history  of  pharyngeal  tonsil  hypertrophy,  after
onsil  removal,  a  significant  increase  in  serum  IGF-1  and
hrelin  levels  was  observed,  as  well  as  a  significant  increase
n  weight,  height,  and  body  mass  index.  Ghrelin  is  predom-
nantly  involved  in  the  regulation  of  the  sleep--wake  cycle;
t  is  associated  with  sleep  deprivation  and  has  a  role  in
egulating  metabolism.  Known  as  the  hunger  hormone,  it
nteracts  with  GH,  leptin,  and  orexins  in  the  sleep  circuit
egulation,  emphasizing  the  role  of  energetic  balance  dur-
ng  sleep.49 According  to  these  authors,  growth  retardation
n  these  children  would  be  related  to  lower  serum  levels  of
GF-1.50
inal considerations
he  nose  is  the  organ  responsible  for  smell,  being  essential
o  breathing,  through  humidification,  heating,  and  filtering
f  the  inhaled  air;  it  also  allows  the  drainage  of  the  paranasalJPED 761 1--6
inuses.  The  upper  airways  undergo  major  changes  during
hildhood  and  pre-school  age:  in  the  first  five  years  of  life,
t  increases  from  6%  to  40%  of  the  nasal  respiratory  volume
f  adults.51
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Growth  and  mouth  breathers  
From  the  first  months  of  life  onwards,  due  to  the  anatom-
ical  conditions,  nasal  breathing  is  preferred,1,52 and  half
of  the  children  have  significant  hypoxemias  if  the  nose  is
congested.52
Mouth  breathing  can  have  dramatic  consequences,
including  growth  retardation,  highlighting  the  importance
of  early  recognition  of  this  health  problem  that  must  be
diagnosed  and  properly  controlled  through  clinical  or  even
surgical  approach.
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